Studying the behavior of these “pro-tumor” immune cells is important because they could be targets for therapies that block their harmful activity
A recent study offers a new approach to treating TNBC: targeting cholesterol synthesis.
Researchers have developed a nanomedicine that increases the penetration and accumulation of chemotherapy drugs in tumor tissues and effectively kills cancer cells in mice.